BMJ Best Practice

Locke Bio Announces Integration with LegitScript

Retrieved on: 
Wednesday, February 15, 2023
BMJ Best Practice, Gold, RSVP, Certification, PT, Internet, Partnership, Health, LegitScript, Meta, Mobile phone, Video game

LOS ANGELES, Feb. 15, 2023 /PRNewswire/ -- Locke Bio, a digital health platform company, today announced a collaboration with LegitScript as part of the next generation evolution of the company's platform.

Key Points: 
  • Locke Bio customers will be connected with a LegitScript team member who can provide expedited, priority reviews and renewals.
  • Locke Bio is currently the first digital health software platform that will be working on additional integration options with LegitScript to enhance speed-to-market for its customers.
  • "These strong success cases and important industry partnerships certainly elevate Locke Bio as the gold standard of digital health platforms," said Cathy Tie, CEO and founder of Locke Bio.
  • Speakers from LegitScript and Locke Bio will be joined by Cole Maudlin, CEO of Gogomeds, a nation-wide, LegitScript approved pharmacy fulfilment network.

Health2047 Launches RecoverX to Empower Physicians with Evidence-Based Augmented Intelligence

Retrieved on: 
Thursday, September 23, 2021
Data Management, Health, Technology, Practice Management, Software, General Health, Knowledge, EBM, NYU Langone Health, Approximation error, BMJ Best Practice, Partnership, Diagnosis, Efficiency, Evidence-based medicine, National academy, Health, Privacy, Medicare, American Medical Association, Patient, BMJ, Physician, MD, Hospital, AI, Indian Medical Association, CEO, Medicine, Arthur, Silicon, Risk, National Academy of Medicine, Technology, Intelligence, Prognosis, Research, Arthur D. Little, Obesity, Mayo Clinic, Prediabetes, Inc., Doctor of Philosophy, Private practice, Columbia University Irving Medical Center, AMA, Industry, Medical device, Management, Pharmaceutical industry, Health insurance, Health2047, RecoverX, BMJ Best Practice, HEALTH2047, RECOVERX, BMJ BEST PRACTICE

Health2047 Inc. , the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has both helped shape and invested in RecoverX, a startup that develops evidence-based medicine (EBM) augmented intelligence (AI) technologies to support and enrich physicians decision-making.

Key Points: 
  • Health2047 Inc. , the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has both helped shape and invested in RecoverX, a startup that develops evidence-based medicine (EBM) augmented intelligence (AI) technologies to support and enrich physicians decision-making.
  • RecoverX is transforming the way physicians practice, moving from the currently overwhelmed human-based present to an evidence-based, AI-empowered future.
  • RecoverX develops evidence-based augmented intelligence technologies to support and enrich medical decision making.
  • RecoverX is a multi-disciplinary medical, AI and engineering team creating advanced technology for augmented intelligence in medicine.